Signal enhancement in immunoassay by modulation of enzymatic catalysis

• US 4,835,099 A
• Filed: 11/20/1986
• Issued: 05/30/1989
• Est. Priority Date: 11/20/1986
• Status: Expired due to Fees

• Current Assignee: Becton, Dickinson & Co
• Original Assignee: Becton, Dickinson & Co
• Inventors: O'Connell, James P., Mize, Patrick D.
• Primary Examiner(s): Kepplinger, Esther M.
• Assistant Examiner(s): NOT, DEFINED
• Application Number:
  US06/932,951
• Time in Patent Office: 922 Days
• Field of Search: 435/7, 435/18, 435/19, 435/20, 435/21, 435/5, 435/24, 435/34, 435/175, 435/188, 435/810, 436/518, 436/536, 436/800, 436/808, 436/821, 436/537, 436/501, 436/823
• US Class Current: 435/7.91
• CPC Class Codes: C07C 225/06 and acyclic
• CPC Class Codes: C07C 45/512 the singly bound functional group being a free hydroxyl group
• CPC Class Codes: C07C 45/52 by dehydration and rearrangement involving two hydroxy groups in the same molecule
• CPC Class Codes: C07C 45/63 by introduction of halogen; by substitution of halogen atoms by other halogen atoms
• CPC Class Codes: C07C 45/673 by change of size of the carbon skeleton
• CPC Class Codes: C07C 49/16 containing halogen
• CPC Class Codes: C07C 49/173 containing halogen
• CPC Class Codes: C07C 49/245 containing six-membered aromatic rings
• CPC Class Codes: C07F 9/091 with hydroxyalkyl compounds with further substituents on alkyl
• CPC Class Codes: C07F 9/12 with hydroxyaryl compounds
• CPC Class Codes: G01N 33/542 with steric inhibition or signal modification, e.g. fluorescent quenching
• CPC Class Codes: G01N 33/581 with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
• CPC Class Codes: Y10S 435/81 Packaged device or kit
• CPC Class Codes: Y10S 436/808 Automated or kit

Abstract

A method for enzyme immunoassay for a ligand suspected to be present in a liquid sample includes signal amplification by use of at least two hydrolases and a blocked fluoroketone for one of the hydrolases. Ligand present in the liquid binds to an antiligand and a hydrolase-labeled tracer. The resulting bound fraction is separated and the hydrolase in the tracer removes the blocking group from the blocked fluoroketone. The fluoroketone activates or inhibits a second hydrolase which catalyzes the conversion of a substrate to a product. The presence or absence of the ligand in the liquid is indicated by a signal, such as a color change or a rate of color change, associated with the product. The invention includes a new class of hydrolase inhibitors and blocked fluoroketones and a kit of materials useful for performing the method of the invention.

Claims

1. A method for the detection of a ligand in a liquid comprising:

(a) combining a first liquid suspected of containing a ligand with an antiligand affixed to a solid support and a tracer, said tracer comprising a first hydrolase, whereby said antiligand binds to said ligand and said tracer binds to one of said antiligand and said ligand to give a bound phase on said support;

(b) separating said support from said first liquid;

(c) contacting said support with a second liquid containing a second hydrolase and a blocked fluoroketone whereby said first hydrolase converts said blocked fluoroketone to a fluoroketone and releases said fluoroketone into said second liquid;

(d) adding to said second liquid a substrate for said second hydrolase whereby conversion of said substrate to a product by said second hydrolase is inhibited by said fluoroketone; and

(e) detecting said ligand by a signal associated with said conversion.

2. The method in accordance with claim 1 wherein said tracer binds to said antiligand and further comprises said ligand having said first hydrolase conjugated thereto.

3. The method in accordance with claim 1 wherein said tracer binds to said ligand and further comprises a second antiligand having said first hydrolase conjugated thereto.

4. The method in accordance with claim 1 wherein said first hydrolase is selected from the group consisting of a peptidase, an esterase, a phosphatase and a glycosidase.

5. The method in accordance with claim 4 wherein said phosphatase is alkaline phosphatase.

6. The method in accordance with claim 1 wherein said ligand is selected from the group of ligands consisting of an antigen, an antibody and a hapten.

7. The method in accordance with claim 1 wherein said antiligand is selected from the group of antiligands consisting of an antigen, an antibody and a plurality of bound antibodies.

8. The method in accordance with claim 1 wherein said second hydrolase is selected from the group consisting of an esterase, a phosphatase and a peptidase.

9. The method in accordance with claim 8 wherein said hydrolase is selected from the group consisting of acetylcholinesterase, butylcholinesterase, carboxyesterase, trypsin, chymotrypsin and pepsin.

10. The method in accordance with claim 1 wherein said substrate is selected from the group consisting of an ester of a nitrophenol, and an ester of indoxyl.

11. The method in accordance with claim 1 wherein the step of detecting by a signal includes detecting a color associated with said substrate.

12. The method in accordance with claim 1 wherein the step of detecting by a signal includes detecting a color associated with said product.

13. The method in accordance with claim 1 further comprising affixing an inert protein to binding sites of said solid support which are unoccupied by said antiligand.

14. The method in accordance with claim 1 wherein said second enzyme hydrolase affixed to said solid support.

15. A method for the detection of an antigen in a liquid comprising

(a) combining a first liquid suspected of containing an antigen with first and second antibodies, said first antibody being affixed to a solid support and said second antibody having alkaline phosphatase conjugated thereto whereby said antigen binds to said first and second antibodies to give a bound phase on said support;

(b) separating said support from said first liquid;

(c) contacting said support with a second liquid containing an esterase and a blocked fluoroketone whereby said alkaline phosphatase converts said blocked fluoroketone to fluoroketone of said esterase, said fluoroketone being released into said second liquid;

(d) adding to said second liquid a chromogen, the conversion of which to a colored product by said esterase is inhibited by said fluoroketone; and

(e) detecting said antigen by detecting inhibition of formation of color in said second liquid.

16. The method in accordance with claim 15 wherein said esterase is selected from the group consisting of a cholinesterase and a carboxyesterase.

17. The method in accordance with claim 15 wherein said chromogen is an ester of a nitrophenol.

18. A method for the detection of an antigen in a liquid comprising:

(a) combining a first liquid suspected of containing an antigen with an antibody affixed to a solid support and with a tracer, said tracer comprising said antigen having alkaline phosphatase conjugated thereto, whereby said antigen and said tracer bind to said antibody to give a bound phase on said support;

(b) separating said support from said first liquid;

(c) contacting said support with a second liquid containing an esterase and a blocked fluoroketone whereby said alkaline phosphatase converts said blocked fluoroketone to fluoroketone of said esterase, said inhibitor being released into said second liquid;

(d) adding to said second liquid a chromogen, the conversion of which to a colored product by said esterase is inhibited by said fluoroketone; and

(e) detecting said antigen by detecting inhibition of formation of color in said second liquid.

19. The method in accordance with claim 18 wherein said esterase is a cholinesterase.

20. The method in accordance with claim 18 wherein said chromogen is an ester of a nitrophenol.

21. A method for the determination of the concentration of a ligand in a liquid comprising:

(a) combining a first liquid suspected of containing a ligand with an antiligand affixed to a solid support and with a tracer, said tracer comprising a first hydrolase, whereby said antiligand binds to said ligand and said tracer binds to one of said ligand and said antiligand, to give a bound phase on said support;

(b) separating said support from said first liquid;

(c) contacting said support with a second liquid containing a second hydrolase and a blocked fluoroketone whereby said first hydrolase converts said blocked fluoroketone to a fluoroketone, said fluoroketone being released into said second liquid;

(d) adding to said second liquid a substrate for said second hydrolase whereby conversion of said substrate to a product having a detectable signal associated therewith by said second hydrolas is inhibited by said fluoroketone;

(e) measuring the magnitude of said signal; and

(f) determining the concentration of said ligand in said first liquid by comparing said magnitude with the magnitude of a signal associate with a product when steps (a) to (e) are repeated with liquid samples containing known quantities of said ligand.

22. The method in accordance with claim 21 wherein said tracer further comprises said ligand and binds to said antiligand.

23. The method in accordance with claim 21 wherein said tracer further comprises a second antiligand which binds to said ligand.

24. The method in accordance with claim 21 wherein said signal is a color change determined with a spectrophotometer.

25. A kit for performing an assay for a liquid comprising an antiligand for a ligand, a first hydrolase and a blocked fluoroketone for a second hydrolase.

26. The kit in accordance with claim 25 wherein said antiligand is attached to a solid support.

27. The kit in accordance with claim 25 wherein said first hydrolase is conjugated to one of said ligand and a secnd antiligand.

28. The kit in accordance with claim 25 further comprising said second hydrolase.

29. The kit in accordance with claim 25 further comprising at least one other reagent selected from the group of reagents consisting of a substrate, antigen, antibody and antibody complex, buffer and saline.

30. The kit in accordance with claim 25 further comprising at least one liquid containing ligand of known concentration.

31. The kit in accordance with claim 25 further comprising a fluid sample substantially free of ligand.

32. The kit in accordance with claim 25 further comprising one or more containers.